No Data
No Data
Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Boundless Bio (NASDAQ:BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers,
Red Door Community Raises More Than $300,000 at Their Annual Luncheon Celebrating Women Working and Living With Cancer
Free cancer support programs get a boost, and Red Door Community member announces a run NEW YORK, May 17, 2024 /PRNewswire/ -- On Wednesday, May 15, Red Door Community hosted their annual Celebrating
Boundless Bio Inc. Shifts Corporate Updates to IR Website
Boundless Bio, Inc. Q1 Loss Climbs
Boundless Bio | 10-Q: Quarterly report
Express News | Boundless Bio Inc: First Patient Dosed in Phase 1/2 Starmap Clinical Trial of Bbi-825 in Patients With Tumors With Resistance Gene Amplifications
No Data
Skinny bulldogOP : Look at the other company in the same industry you will know. The problem is, how high it can go.